Wim H Kruit

Author PubWeight™ 7.58^‹?›

Rank	Title	Journal	Year	PubWeight™‹?›
1	Extended schedule, escalated dose temozolomide versus dacarbazine in stage IV melanoma: final results of a randomised phase III study (EORTC 18032).	Eur J Cancer	2011	1.78
2	Ulceration and stage are predictive of interferon efficacy in melanoma: results of the phase III adjuvant trials EORTC 18952 and EORTC 18991.	Eur J Cancer	2011	1.28
3	Autoimmune antibodies and recurrence-free interval in melanoma patients treated with adjuvant interferon.	J Natl Cancer Inst	2009	1.11
4	Phase III trial comparing adjuvant treatment with pegylated interferon Alfa-2b versus observation: prognostic significance of autoantibodies--EORTC 18991.	J Clin Oncol	2010	1.00
5	Adjuvant ganglioside GM2-KLH/QS-21 vaccination versus observation after resection of primary tumor > 1.5 mm in patients with stage II melanoma: results of the EORTC 18961 randomized phase III trial.	J Clin Oncol	2013	0.92
6	Serum concentrations of pegylated interferon alpha-2b in patients with resected stage III melanoma receiving adjuvant pegylated interferon alpha-2b in a randomized phase III trial (EORTC 18991).	Cancer Chemother Pharmacol	2009	0.92
7	Changes of ferritin and CRP levels in melanoma patients treated with adjuvant interferon-α (EORTC 18952) and prognostic value on treatment outcome.	Melanoma Res	2011	0.79